Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$91.5M |
| 2 |
VRN
Veren
VRN
|
+$44.4M |
| 3 |
Perrigo
PRGO
|
+$25.6M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$7.63M |
| 5 |
Liberty Global Class C
LBTYK
|
+$6.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$51.2M |
| 2 |
COLE
COLE REAL ESTATE INVESTMENTS, INC COM
COLE
|
+$43.4M |
| 3 |
ExxonMobil
XOM
|
+$41.4M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$27.7M |
| 5 |
Microsoft
MSFT
|
+$27.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.36% |
| 2 | Technology | 13.06% |
| 3 | Energy | 11.79% |
| 4 | Industrials | 11.18% |
| 5 | Consumer Staples | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPIQ
2101
DELISTED
EPIQ SYSTEMS INC
EPIQ
| $521K | ﹤0.01% |
38,200
+6,700
| +21% | +$96.7K |
|
2102
Towne Bank
TOWN
$3.42B
| $520K | ﹤0.01% |
33,500
+15,400
| +85% | +$234K |
|
2103
PTC Therapeutics
PTCT
$6.16B
| $518K | ﹤0.01% |
19,820
+13,820
| +230% | +$371K |
|
|
SZYM
2104
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $518K | ﹤0.01% |
44,600
+15,600
| +54% | +$184K |
|
|
ASEI
2105
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
| $517K | ﹤0.01% |
7,700
+1,700
| +28% | +$116K |
|
|
GHDX
2106
DELISTED
Genomic Health, Inc.
GHDX
| $516K | ﹤0.01% |
19,600
+4,100
| +26% | +$118K |
|
|
ESI
2107
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
| $516K | ﹤0.01% |
18,000
+4,200
| +30% | +$139K |
|
|
EXK
2108
Endeavour Silver
EXK
$3.08B
| $514K | ﹤0.01% |
118,800
+23,600
| +25% | +$111K |
|
2109
Option Care Health
OPCH
$3.67B
| $514K | ﹤0.01% |
18,400
+4,375
| +31% | +$135K |
|
|
FFIC
2110
DELISTED
Flushing Financial
FFIC
| $512K | ﹤0.01% |
24,300
+6,800
| +39% | +$139K |
|
|
PTRY
2111
DELISTED
PANTRY INC (THE)
PTRY
| $511K | ﹤0.01% |
33,300
+4,700
| +16% | +$71K |
|
2112
Mistras Group
MG
$604M
| $510K | ﹤0.01% |
22,400
+4,400
| +24% | +$102K |
|
|
REN
2113
DELISTED
Resolute Energy Corporaton
REN
| $510K | ﹤0.01% |
14,180
+3,080
| +28% | +$129K |
|
|
CAI
2114
DELISTED
CAI International, Inc.
CAI
| $508K | ﹤0.01% |
20,600
+4,300
| +26% | +$97K |
|
2115
KRONOS Worldwide
KRO
$994M
| $507K | ﹤0.01% |
30,400
+5,800
| +24% | +$93.4K |
|
|
MOVE
2116
DELISTED
MOVE INC COM STK NEW (DE)
MOVE
| $506K | ﹤0.01% |
43,800
+8,000
| +22% | +$108K |
|
2117
US Physical Therapy
USPH
$1.22B
| $505K | ﹤0.01% |
14,600
+2,500
| +21% | +$83K |
|
2118
Allegiant Air
ALGT
$2.41B
| $504K | ﹤0.01% |
4,500
+1,000
| +29% | +$102K |
|
|
LDR
2119
DELISTED
Landauer Inc
LDR
| $503K | ﹤0.01% |
11,100
+2,400
| +28% | +$118K |
|
2120
PhenixFIN
PFX
$89.8M
| $502K | ﹤0.01% |
1,843
+298
| +19% | +$83.2K |
|
2121
Medifast
MED
$133M
| $497K | ﹤0.01% |
17,100
+3,100
| +22% | +$83K |
|
|
AFFX
2122
DELISTED
Affymetrix Inc
AFFX
| $496K | ﹤0.01% |
69,600
+16,100
| +30% | +$130K |
|
|
BMTC
2123
DELISTED
Bryn Mawr Bank Corp
BMTC
| $494K | ﹤0.01% |
17,200
+2,900
| +20% | +$82.7K |
|
|
ISSI
2124
DELISTED
INTEGRATED SILICON SOLUTN INC
ISSI
| $493K | ﹤0.01% |
31,700
+7,500
| +31% | +$94K |
|
2125
BlackRock TCP Capital
TCPC
$328M
| $492K | ﹤0.01% |
29,700
+600
| +2% | +$10.3K |
|
Similar funds
Swiss National Bank's Q1 2014 Portfolio in Review
As of Q1 2014, Swiss National Bank held 2,515 positions worth $25.5B, down 0.58% from $25.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Trading was light in Q1 2014: portfolio turnover was 1.2%. Swiss National Bank opened 8 new positions and exited 21, leaving the 2,515-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Technology and Energy.
- Swiss National Bank's largest Q1 2014 buy was Veren: 1,374,746 shares worth $46M.
- Swiss National Bank added most to Verizon in Q1 2014, an estimated $91.5M increase.
- Swiss National Bank's biggest Q1 2014 reduction was Apple, cutting an estimated $51.2M.
- Swiss National Bank fully exited COLE REAL ESTATE INVESTMENTS, INC COM in Q1 2014, selling an estimated $43.4M.
- Swiss National Bank's ten largest holdings make up 13% of its $25.5B portfolio in Q1 2014.
- Swiss National Bank opened 8 new positions and closed 21 in Q1 2014.
- Swiss National Bank's portfolio value fell 0.58% quarter-over-quarter to $25.5B.
Based on Swiss National Bank's 13F filing for Q1 2014, filed 6 May 2014.